Carisma TherapeuticsCARM
13F holders, Q2 2026 (June 30)1holders −2
0new positions
2sold out
$0.01avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Carisma Therapeutics Inc. (CARM) in their 13F filings, down 2 from Q1 2026. 0 opened new positions and 2 sold out. The largest holder was Union Bancaire Privee, UBP SA ($4).
- Company
- Carisma Therapeutics Inc.
- CUSIP
- 14216R101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $48K |
All 13F filers, Q1 2026 → Q2 2026: 1,473,440 shares sold, net −1,473,440 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Union Bancaire Privee, UBP SA | 0.00% | No change | 785 | $4 |
"% of holder's portfolio" is CARM's weight in each manager's 13F, not the share of Carisma Therapeutics Inc. the manager owns.